Stock ANNX ANNEXON, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Annexon, Inc.

Equities

ANNX

US03589W1027

Market Closed - Nasdaq
Other stock markets
 04:00:03 2024-05-31 pm EDT 		5-day change 1st Jan Change
4.84 USD +2.33% Intraday chart for Annexon, Inc. +2.98% +6.61%
May. 14 Transcript : Annexon, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM
May. 13 Annexon, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
GL
Transcript : Annexon, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
GL
Annexon, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Annexon Biosciences to Present at the Bank of America Health Care Conference
GL
Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
GL
Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
AQ
Annexon, Inc. Presents New Neuro Protection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy
CI
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting
GL
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting
AQ
ANNEXON REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(4)
AQ
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
GL
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
GL
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
AQ
JPMorgan Raises Price Target on Annexon to $13 From $11, Maintains Overweight Rating
MT
Wells Fargo Adjusts Price Target on Annexon to $12 From $11, Maintains Overweight Rating
MT
Annexon Q4 Loss Narrows
MT
Annexon, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones
GL
Annexon, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANNX Stock
  4. News Annexon, Inc.